Aerovate Therapeutics is a biopharmaceutical company focused on developing treatments for pulmonary vascular diseases. With an innovative pipeline and cutting-edge research, they aim to revolutionize the way these diseases are diagnosed and managed, ultimately improving patient outcomes.
Notification